PLK1 and esophageal squamous cell carcinoma: In GSDME high-expressed ESCC cell lines, the serine/threonine protein kinase PLK1 inhibitor BI2536 combined with cisplatin can increase chemosensitivity by inducing GSDMD-mediated pyroptosis [28].